These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3125374)

  • 21. Age-related changes in the chronotropic effect and the enzymic decarboxylation of L-threo-3,4-dihydroxphenylserine in the rat heart.
    Araki H; Fujiwara H; Tanaka C
    J Pharm Pharmacol; 1981 Dec; 33(12):778-82. PubMed ID: 6121849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of monoamine oxidase by 3,4-dihydroxyphenylserine.
    Naoi M; Nagatsu T
    J Neurochem; 1986 Aug; 47(2):604-7. PubMed ID: 3090204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catecholamine metabolism during additional administration of DL-threo-3,4-dihydroxyphenylserine to patients with Parkinson's disease.
    Teelken AW; van den Berg GA; Muskiet FA; Staal-Schreinemachers AL; Wolthers BG; Lakke JP
    J Neural Transm Park Dis Dement Sect; 1989; 1(3):177-88. PubMed ID: 2476157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of L-threo-DOPS, an L-noradrenaline precursor, on locus coeruleus-originating neurons in spinal trigeminal nucleus.
    Sasa M; Ohno Y; Nabatame H; Yoshimura N; Takaori S
    Brain Res; 1987 Sep; 420(1):157-61. PubMed ID: 3119149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new metabolic pathway of L-threo-3,4-dihydroxyphenylserine, a precursor amino acid of norepinephrine, in the brain. Studies by in vivo microdialysis.
    Maruyama W; Nakahara D; Naoi M
    J Neural Transm Park Dis Dement Sect; 1994; 7(1):21-33. PubMed ID: 8579767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal by L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS), a L-norepinephrine precursor of reserpine- or tetrabenazine-induced hypothermia.
    Katsuyama M; Kato T; Karai N; Nakamura M; Katsube J
    Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):61-70. PubMed ID: 3099671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of L-threo-DOPS, a noradrenaline precursor, on the long-term potentiation in the rat hippocampal mossy fiber-CA3 region.
    Sakai N; Sasa M; Ishihara K; Komure O; Tanaka C; Takaori S
    Brain Res; 1991 Dec; 567(2):267-73. PubMed ID: 1817730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroendocrinological effects of L-threo-3, 4-dihydroxyphenylserine (DOPS), a putative norepinephrine precursor, on healthy volunteers.
    Semba J; Nankai M; Okubo Y; Kato M; Matsuura M; Takahashi R
    Jpn J Psychiatry Neurol; 1990 Mar; 44(1):73-8. PubMed ID: 2113967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of L-threo-dihydroxyphenylserine on norepinephrine metabolism in rat brain.
    Semba J; Takahashi R
    Psychiatry Res; 1985 Aug; 15(4):319-26. PubMed ID: 3934694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the central action of L-threo-3,4-dihydroxyphenyl-serine (L-threo-DOPS) in FLA-63-treated mice.
    Kato T; Katsuyama M; Karai N; Nakamura M; Katsube J
    Pharmacol Biochem Behav; 1987 Feb; 26(2):407-11. PubMed ID: 3106991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increase in norepinephrine turnover after tyrosine or DL-threo-3,4-dihydroxyphenylserine (DL-threo-DOPS).
    Gibson CJ
    Life Sci; 1988; 42(1):95-102. PubMed ID: 3121971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preferential decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat renal tissues.
    Soares-da-Silva P
    Gen Pharmacol; 1993 Jan; 24(1):75-81. PubMed ID: 8482506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of hypotensive and brain catecholamine depleting effects by erythro- and threo-alpha-methyl DOPS.
    Castellucci A; Bonacchi G; Bacciarelli C; Boni P
    Arzneimittelforschung; 1979; 29(1):27-31. PubMed ID: 582113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. d,l-threo-3,4-dihydroxyphenylserine restores sympathetic control and cures orthostatic hypotension in dopamine beta-hydroxylase deficiency.
    Man in 't Veld AJ; Boomsma F; van den Meiracker AH; Julien C; Lenders J; Schalekamp MA
    J Hypertens Suppl; 1988 Dec; 6(4):S547-9. PubMed ID: 3149290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uptake of L-threo-dihydroxyphenylserine into human brain synaptosomes.
    Naoi M; Nagatsu T
    J Neural Transm; 1987; 70(1-2):51-61. PubMed ID: 3117973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of the reserpine-induced ptosis by L-threo-3,4-dihydroxy-phenylserine (L-threo-DOPS), a (-)-norepinephrine precursor, and its potentiation by imipramine or nialamide.
    Kato T; Katsuyama M; Karai N; Hirose A; Nakamura M; Katsube J
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):243-6. PubMed ID: 3086752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-threo-3,4-dihydroxyphenylserine, a noradrenaline precursor, inhibits dopamine release and metabolism in the rat striatum in vivo.
    Mizoguchi K; Tanaka M; Yokoo H; Yoshida M; Tsuda A
    Experientia; 1992 Dec; 48(11-12):1133-4. PubMed ID: 1473578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing CNS norepinephrine levels by the precursor L-DOPS facilitates beam-walking recovery after sensorimotor cortex ablation in rats.
    Kikuchi K; Nishino K; Ohyu H
    Brain Res; 2000 Mar; 860(1-2):130-5. PubMed ID: 10727631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beneficial attenuating effect of L-threo-3,4-dihydroxyphenylserine on postural hypotension in anesthetized rats.
    Satoh S; Oyabe A; Tanno M; Suzuki-Kusaba M
    Arzneimittelforschung; 1989 Sep; 39(9):1123-9. PubMed ID: 2511849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute effects of toluene on circadian rhythms of sleep-wakefulness and brain monoamine metabolism in rats.
    Arito H; Tsuruta H; Nakagaki K
    Toxicology; 1984 Dec; 33(3-4):291-301. PubMed ID: 6083632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.